POSC52 Cost-Effectiveness of Atezolizumab in Association with Bevacizumab for Patients with Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Using a French Real-World Evidence Database
Abstract
Authors
L Gaugain C Laurendeau M Gilberg B Mazaleyrat V Genestier